At the Vaccine Center, part of the Department of Medicine’s Division of Infectious Diseases and Immunology at NYU Langone Health, renowned experts in vaccine research merge basic science, clinical studies, and public health outreach to prevent the spread of disease.
Our inaugural director, Mark J. Mulligan, MD, has been an international leader in infectious disease research programs for more than three decades, and his pioneering work has profoundly advanced the field.
Using the latest technologies from fields such as epidemiology, immunology, and microbiology, we lead collaborative research projects designed to identify safe and effective vaccines for infectious illnesses including measles and influenza. We also develop vaccines for noninfectious conditions including cancers, autoimmune disorders, brain conditions, and chronic diseases.
Our goals reach beyond just discovering the next vaccine. We care deeply about protecting public health, and collaborate with communities to improve how we communicate information about vaccines. We aim to increase access to care and combat vaccine hesitancy in New York City and around the world.
As an international hub for cutting-edge research, we have the expertise and resources to prevent a public health emergency and realize the potential of vaccines.
Vaccine Center Education
On November 2, 2019, Dr. Mulligan and other nationally and internationally recognized leaders in infectious diseases will host a course titled Current Topics in Infectious Disease. This course will be offered through NYU Langone’s continuing medical education program and will cover a broad array of topics relevant to recent advances in the diagnosis, treatment, and prevention of infectious disease.
Registration is now open.
Also in November, Dr. Mulligan and other experts in vaccine research will lead a clinical vaccinology course hosted by the National Foundation for Infectious Diseases (NFID). This two-day course is open to NYU Langone fellows and faculty and will focus on new developments and best practices in the field.
Registration is now open.
For general inquiries about the Vaccine Center, please contact Kaylie Patrick, administrator, at firstname.lastname@example.org or 646-501-2075.
For inquiries related to our clinical studies, please contact Stephanie Tenzigolski, clinical research operations manager, at email@example.com or 212-263-3570.
Health Officials Say Measles Outbreak Has Ended in New York City
Public Health Officials Confront Dangerous Ideas About Measles
How Long Does the Flu Shot Last?
How the Anti-Vaccine Movement was Decades in the Making
The Biggest Cause of the Measles Crisis is Vaccine Hesitancy, Not Avoidance
Dr. Mark Mulligan explains the impact of vaccinations: "One measles shot provides immunity to 93% of vaccinated persons, and the recommended two shots provide protection to 97%."